loratadine has been researched along with Intestinal Obstruction in 2 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Intestinal Obstruction: Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Findings were conclusive with subserosal type of eosinophilic gastroenteritis and the patient's treatment started with a combination of parenteral methylprednisolone and oral loratadine." | 7.79 | Enhanced therapeutic response with addition of loratadine in subserosal eosinophilic gastroenteritis. ( Alibegović, E; Jovanović, P; Mustedanagić-Mujanović, J; Salkić, NN, 2013) |
| " Findings were conclusive with subserosal type of eosinophilic gastroenteritis and the patient's treatment started with a combination of parenteral methylprednisolone and oral loratadine." | 3.79 | Enhanced therapeutic response with addition of loratadine in subserosal eosinophilic gastroenteritis. ( Alibegović, E; Jovanović, P; Mustedanagić-Mujanović, J; Salkić, NN, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salkić, NN | 1 |
| Mustedanagić-Mujanović, J | 1 |
| Jovanović, P | 1 |
| Alibegović, E | 1 |
| Farinas, E | 1 |
| Honig, P | 1 |
2 other studies available for loratadine and Intestinal Obstruction
| Article | Year |
|---|---|
Enhanced therapeutic response with addition of loratadine in subserosal eosinophilic gastroenteritis.
Topics: Anti-Allergic Agents; Ascites; Biomarkers; Drug Therapy, Combination; Enteritis; Eosinophilia; Eosin | 2013 |
Upper gastrointestinal obstruction associated with Claritin-D 24 Hour Extended Release tablets.
Topics: Administration, Oral; Adult; Aged; Delayed-Action Preparations; Esophageal Stenosis; Female; Gastroi | 1997 |